Stocks and Investing Stocks and Investing
Tue, November 22, 2022
[ 12:00 AM ] - United States, WOPRAI
Dan Brennan Maintained (A) at Buy with Increased Target to $168 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Brandon Couillard Maintained (A) at Strong Buy with Increased Target to $168 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Matthew Sykes Maintained (A) at Strong Buy with Increased Target to $160 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Derik De Bruin Maintained (A) at Strong Buy with Increased Target to $164 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Timothy Daley Maintained (A) at Hold with Increased Target to $150 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Daniel Arias Maintained (A) at Hold and Held Target at $153 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Catherine Schulte Maintained (A) at Buy with Increased Target to $170 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Puneet Souda Maintained (A) at Buy and Held Target at $160 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Vincent Sinisi Maintained (WTW) at Hold with Decreased Target to $240 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Myles Walton Downgraded (WWD) to Hold on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Angus Kelleher-Ferguson Downgraded (VNO) to Hold on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Colin Sebastian Downgraded (VRM) to Hold and Decreased Target to $160 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Mark Fitzgibbon Downgraded (WNEB) to Hold and Held Target at $10 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Robert Dodd Maintained (WHF) at Buy with Decreased Target to $15 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Phillips Maintained (WRB) at Hold with Increased Target to $50 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
John Blackledge Downgraded (W) to Hold and Decreased Target to $38 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Abhishek Sinha Initiated (WBX) at Buy and Held Target at $16 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Charles Ryhee Upgraded (WBA) to Buy and Increased Target to $54 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Keith Weiss Maintained (WDAY) at Buy with Decreased Target to $220 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Ken Newman Maintained (URI) at Buy with Increased Target to $425 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Thomas Champion Maintained (AMZN) at Buy with Decreased Target to $119 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
John McNulty Maintained (APD) at Buy with Increased Target to $390 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Phillips Maintained (AON) at Sell with Increased Target to $255 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Simeon Siegel Maintained (URBN) at Hold with Increased Target to $24 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Ike Boruchow Maintained (URBN) at Hold with Increased Target to $25 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Dana Telsey Maintained (URBN) at Buy with Increased Target to $33 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Paul Lejuez Maintained (URBN) at Strong Buy with Decreased Target to $30 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Rich Hilliker Initiated (UPLD) at Hold and Held Target at $8 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Phillips Maintained (TRV) at Hold with Increased Target to $190 on, Nov 22nd, 2022
[ 12:00 AM ] - United States, WOPRAI
Thomas Smith Initiated (TRVI) at Buy and Held Target at $6 on, Nov 22nd, 2022

Thomas Smith Initiated (TRVI) at Buy and Held Target at $6 on, Nov 22nd, 2022


Published on 2024-10-28 00:17:49 - WOPRAI, Thomas Smith
  Print publication without navigation


Thomas Smith of SVB Leerink, Initiated "Trevi Therapeutics, Inc." (TRVI) at Buy and Held Target at $6 on, Nov 22nd, 2022.

Thomas has made no other calls on TRVI in the last 4 months.



There is 1 other peer that has a rating on TRVI. Out of the 1 peers that are also analyzing TRVI, 0 agree with Thomas's Rating of Hold.



This is the rating of the analyst that currently disagrees with Thomas

  • Serge Belanger of "Needham" Maintained at Strong Buy with Decreased Target to $8 on, Friday, November 11th, 2022

Contributing Sources